Enliven Therapeutics, Inc. ELVN 深 沪
交易中 10-06 11:18:33 美东时间
42.24
-3.230
-7.10%
华盛通- 最 高62.00
- 今 开45.38
- 成交量 48.53万股
- 最 低 41.22
- 昨 收 45.47
- 总市值 0
- 52周最高 62.32
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 14.785
- 委 比 -81.90%
- 总股本 --
- 历史最高 62.32
- 量 比 2.31
- 振 幅 45.70%
- 历史最低 1.10
- 每 手 1
- 风险率 14.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Crude Oil Edges Higher; Driven Brands Posts Upbeat Earnings
US stocks rise with Nasdaq up 150 points. Dow up 0.54%, Nasdaq up 0.63%, S&P 500 up 0.26%. Industrials and Enliven Therapeutics lead gains. Dana Inc and Oracle Corp down. Oil up 0.7%, gold down 0.7%. European and Asian markets mixed. Initial jobless claims and producer prices higher than expected.
06-11 23:44
Enliven Therapeutics: Q4 Earnings Insights
Enliven Therapeutics (NASDAQ:ELVN) released its Q4 earnings on Tuesday, March 3...
03-04 05:48
Tiny Biotech Terns Takes Aim At Novartis' Leukemia Blockbuster
Terns Pharma presented positive data from ongoing CARDINAL trial of TERN-701 in CML patients, showing high MMR rates and good safety profile.
2025-12-09 20:51
HC Wainwright & Co. Initiates Coverage On Enliven Therapeutics with Buy Rating, Announces Price Target of $37
HC Wainwright & Co. analyst Robert Burns initiates coverage on Enliven Therapeutics (NASDAQ:ELVN) with a Buy rating and announces Price Target of $37.
2024-09-09 18:27
